{{Rsnum
|rsid=1327118
|Gene=LEPR
|Chromosome=1
|position=65419886
|Orientation=plus
|GMAF=0.455
|Gene_s=LEPR,LEPROT
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 18.9 | 53.2 | 27.9
| HCB | 75.9 | 21.2 | 2.9
| JPT | 68.1 | 30.1 | 1.8
| YRI | 13.7 | 45.9 | 40.4
| ASW | 15.8 | 52.6 | 31.6
| CHB | 75.9 | 21.2 | 2.9
| CHD | 72.2 | 26.9 | 0.9
| GIH | 36.6 | 46.5 | 16.8
| LWK | 21.8 | 46.4 | 31.8
| MEX | 36.2 | 41.4 | 22.4
| MKK | 14.8 | 52.3 | 32.9
| TSI | 15.7 | 49.0 | 35.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=22666399
|Title=Tumor Necrosis Factor-α Induced Protein 8 Polymorphism and Risk of Non-Hodgkin's Lymphoma in a Chinese Population: A Case-Control Study
|OA=1
}}

{{PMID Auto
|PMID=23840460
|Title=Lymphotoxin Alpha (LTA) Polymorphism Is Associated with Prognosis of Non-Hodgkin's Lymphoma in a Chinese Population
|OA=1
}}

{{on chip | Affy GenomeWide 6}}